Protein-losing enteropathy after the Fontan procedure - A cardiologist's and gastroenterologist's perspective. | ScholarDeck

Paper

Protein-losing enteropathy after the Fontan procedure - A cardiologist's and gastroenterologist's perspective.

New research · Thoracic Surgery

Annals of pediatric cardiology · 3w

ReviewAnnals of pediatric cardiology· 2026

Protein-losing enteropathy after the Fontan procedure - A cardiologist's and gastroenterologist's perspective.

Natalia Nawara-Węgrzyn, Łukasz Cichy, Kinga Kowalska-Duplaga, Aleksandra Morka

Read paper

Congenital Cardiac SurgeryReviewTreatmentQ3IF 0.7

Protein-losing enteropathy complicates Fontan circulation in about 1 in 8 patients

Protein-losing enteropathy after the Fontan procedure - A cardiologist's and gastroenterologist's perspective.

Natalia Nawara-Węgrzyn … Aleksandra Morka

Annals of pediatric cardiology · 2026

Results

12%

nearly 1 in 8 with a single-ventricle heart develop this complication

More results

When conservative and interventional strategies fail, heart transplantation remains the definitive option.

“

Conclusion

This review summarizes current concepts in protein-losing enteropathy pathophysiology and therapeutic approaches, with emphasis on lymphatic dysfunction and evolving adjunctive targets.

Read paper

0 comments

No comments yet. Be the first.

ScholarDeck.

Join the discussion on this paper

Create your profile

Related papers

Latest Foundational

Cohort Study

OR 0.14

Each rise in this conduction velocity index sharply lowers odds of inducible ventricular tachycardia

Cohort Study

3 vs 5 donors

whole blood exposed infants to fewer donors than standard blood

AI / Informatics

odds ratio, 2.5

grade 3 diastolic dysfunction more than doubles odds of in-hospital death

Cohort Study

OR = 3.70

high comorbidity burden nearly quadruples odds of major complications

Cohort Study

29%

removing 25+ nodes cut deaths after chemo alone, not chemoradiation

Cohort Study

25 vs. 30 min

robot-assisted approach cleared these nodes faster than standard minimally invasive surgery

Cohort Study

10.0% vs. 32.6%

vr cut persistent pain at 3 months to about a third of usual rates

Cohort Study

90.6%

specificity was high, so a positive result reliably confirms regurgitation risk